ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Guest Editorial – Interlocking Tragedies: Lance Armstrong and CPRIT

February 15, 2013

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980